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ABSTRACT
Background: A late-relapse germ cell tumor (GCT) might 
contain malignant non-germ cell tumor cells, known 
as „somatic-type malignancy” (SM). Development of 
secondary SM is extremely rare and occurs in only 1% 
of patients with GCT.
Case study: We present the case of a 42-year-old patient 
who developed retroperitoneal tumor with duodenal and 
right colon involvement 6 years after he underwent left 
orchidectomy for stage IIC mixed GCT (95% seminoma, 
5% teratoma). Since the tumor markers for germline 
tumor were normal, another type of tumor was highly 
suspected, most likely a malignant alteration of the 
residual teratoma. Tumor was completely removed and 
pathological report suggested undifferentiated sarcoma.
Conclusion: R0 resection and postoperative patient 
follow-up by the protocol for at least 6 years after 
orhidectomy is the key to successful treatment of GCT. 
Malignant tumor transformations are rare, but still 
possible so clinicians should be aware of the importance 
of frequent and adequate patient monitoring.
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INTRODUCTION 
Testicle is an organ with double function consisting 
of embryonic and supporting cells. The process of 
spermatogenesis emerges from the germ cells, while 
the supporting (Leydig) cells represent an endocrine 
part of the organ which releases  male sex hormone 
- testosterone.  While tumors can originate from both 
types of cells, tumors of germinal epithelium are far 
more common [1].
Germ cell tumors represent 95% of all testicular tumors, 
and are among the most common tumors of young 
men aged 15 to 34 years. Their incidence has increased 
in the last 30 years, especially in industrialized countries. 
Multidisciplinary approach, advance in diagnostic 
methods, surgical technique and chemotherapy have 
led to increased survival rate of more than 90% and 
20 years ago, that value was mortality rate of this 
malignancy [2-4]. 
Seminomas have the best prognosis, while prognosis 
of non-seminomatous tumors depends on the 
presence and type of its different components- 
embryonic carcinoma, teratoma, yolk-sack tumors, 
choriocarcinoma, and can also be mixed GCT [5,6].
Despite appropriate treatment, 10 to 30% of 
patients may experience relapse within 2 years after 
orhidectomy. A very late relapse (over 5 years following 
orhidectomy) happens even more rarely, in about only 
1% of cases, but such tumors often contain malignant 
cells of non-germinal type (somatic-type malignancy, 
SM). It is possible that malignant transformation arises 
either from the pre-existing teratomatous component 
of the tumor, or from the totipotent germ cell. The most 
common type of SM associated with GCT is the sarcoma 
in more than 50% of cases, with rhabdomyosarcoma 
being its most common subtype. It is followed by 
neuroectodermal tumors, adenocarcinomas and 
undifferentiated sarcomas [7-9].
Sarcomas are a heterogeneous group of rare solid 
tumors of mesenchymal origin with specific clinical 
and pathological features. They are usually divided 
into two major categories - soft tissue sarcomas (fat, 
muscle, nerve and nerve envelopes, blood vessels and 
other connective tissues) and sarcomas of the bone. 
Anatomical localization of the tumor process is a very 
important variable that affects the choice of treatment 
method and outcome of the disease [7,9].
Accordingly, the NCCN soft tissue sarcoma (STS) guidelines 
are classified into the following subcategories: STS of 
extremities, surface / placed on the trunk, head or neck; 
retroperitoneal or intraabdominal STS; GIST; desmoid 
tumors (aggressive fibromatosis); rhabdomyosarcomas. 
STSs most commonly metastasize into the lungs, while 
abdominal STSs are mainly conveyed in the liver and 
peritoneum [10].
Due to the rare occurrence and complexity of this 
condition, an optimal treatment strategy has not yet 
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been established. For this reason it is important to 
involve multidisciplinary teams of experts in treating 
STS and follow evidence-based recommendations. 
CASE STUDY
A 42-year-old patient has been hospitalized at the 
Abdominal Surgery Department because of epigastric 
pain, anorexia, nausea and vomit soon after meal intake. 
In addition, he had insomnia and night sweating. He had 
a history of stage IIC mixed testicular carcinoma (95% 
seminoma, 5% teratoma) which was treated in 2012. He 
underwent left-sided orhidectomy and had 4 cycles of 
adjuvant chemotherapy by BEP protocol (bleomycin / 
etoposide / cis-platinum), followed by retroperitoneal 
lymph node dissection. Due to iatrogenic urethral 
injury, left nephrectomy was performed in the same 
procedure. Thereafter, the patient did not show up for 
regular urological and oncological follow-ups.
An abdominal CT revealed a large retroperitoneal 
tumor with compression and partial obstruction of the 
duodenum. Since tumor markers for germinative tumor 
were normal, another type of tumor was highly suspected, 
most likely a malignant alteration of residual teratoma. 
Surgery was indicated and included complete 
extirpation of the retroperitoneal tumor, partial 
duodenal and jejunal resection with terminolateral 
duodenojejunal anastomosis, left hemicolectomy 
and apendectomy. Histopathological suggested 
undifferentiated sarcoma.
Postoperative course was complicated with infected 
intraabdominal collection (E.fecalis, C. albicans and C. 
Dubliniensis), increased inflammatory parameters and 
elevated liver enzymes (AF 436; GGT 690; AA 161). 
Antibiotic and supportive therapy with percutaneous 
drainage of collections was done and patient’s condition 
improved and was discharged on postoperative day 24. 
DISCUSSION
Malignant transformation of germ cell tumors into 
somatic malignancy is rare clinical scenario and 
sarcomas are the most commonly reported type of 
malignancy observed in GCTs. Hypothesis regarding 
the origin of malignant transformation suggests that 
the sarcoma may arise from “malignant transformation” 
of teratomatous mesenchyme [11,13]. 
Prior to selecting the treatment method for STS, it is 
necessary to do a biopsy and set a pathohistological 
diagnosis. The correct diagnosis is very important in 
primary testicular tumors as well as in the metastases 
since it will allow appropriate therapy. The most 
frequently selected method of treatment is the surgical 
resection of the tumor and all affected structures, and 
it is of utmost importance that the resection margins 
are free of malignant tissue. This is the only potentially 
curative option for patients with retroperitoneal / 
intraabdominal STS [11,12].
Patients with stage I disease have good prognosis, but 
in metastatic disease it is generally poor. Radical surgery 
is the only curative modality, although there have been 
a couple of findings on achieving promising results 
with Doxorubicin-based chemotherapy for transformed 
tumour component [13].
A large study on 500 subjects showed median survival 
of 103 months for complete resection compared to 18 
months for incomplete resection. Radiotherapy can be 
used as a preoperative procedure in resectable tumors, 
or as a primary treatment for non-curable ones, but is 
not appropriate substitute for radical surgical resection 
[14].
A deeper understanding of the biology of this 
phenomenon is essential for clinicians who are involved 
in such malignancies in order to improve treatment 
outcomes.
CONCLUSION
R0 resection and postoperative patient follow-up by 
the protocol for at least 6 years after orhidectomy is the 
key to successful treatment of GCT. Malignant tumor 
transformations are rare, but still possible so clinicians 
should be aware of the importance of frequent and 
adequate patient monitoring.
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FIGURES AND CAPTIONS
Figure 1. Abdominal CT scan showing large retroperitoneal tumour mass which caused duodenal obstruction
 
Figure 2. Surgical specimen after “en block” resection of 
tumor, fourth segment of duodenum and proximal part 
of jejunum
 
Figure 3. Tumor as seen after the fibrous capsule was 
partially removed
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